CCEL vs. MUSA
Compare and contrast key facts about Cryo-Cell International, Inc. (CCEL) and Murphy USA Inc. (MUSA).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CCEL or MUSA.
Correlation
The correlation between CCEL and MUSA is 0.04, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
CCEL vs. MUSA - Performance Comparison
Key characteristics
CCEL:
-0.58
MUSA:
0.33
CCEL:
-0.58
MUSA:
0.69
CCEL:
0.93
MUSA:
1.09
CCEL:
-0.63
MUSA:
0.50
CCEL:
-1.56
MUSA:
1.16
CCEL:
23.80%
MUSA:
9.23%
CCEL:
65.91%
MUSA:
28.34%
CCEL:
-96.67%
MUSA:
-33.72%
CCEL:
-56.42%
MUSA:
-19.97%
Fundamentals
CCEL:
$39.43M
MUSA:
$10.04B
CCEL:
$0.01
MUSA:
$24.09
CCEL:
487.92
MUSA:
21.05
CCEL:
0.00
MUSA:
1.86
CCEL:
1.23
MUSA:
0.56
CCEL:
9.72
MUSA:
11.86
CCEL:
$32.10M
MUSA:
$15.40B
CCEL:
$24.33M
MUSA:
$1.50B
CCEL:
$3.99M
MUSA:
$833.60M
Returns By Period
In the year-to-date period, CCEL achieves a -28.99% return, which is significantly lower than MUSA's -11.40% return. Over the past 10 years, CCEL has underperformed MUSA with an annualized return of 11.47%, while MUSA has yielded a comparatively higher 22.47% annualized return.
CCEL
-28.99%
-3.32%
-34.99%
-38.02%
-2.26%
11.47%
MUSA
-11.40%
-4.57%
-12.54%
9.39%
31.98%
22.47%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CCEL vs. MUSA — Risk-Adjusted Performance Rank
CCEL
MUSA
CCEL vs. MUSA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Cryo-Cell International, Inc. (CCEL) and Murphy USA Inc. (MUSA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
CCEL vs. MUSA - Dividend Comparison
CCEL's dividend yield for the trailing twelve months is around 9.81%, more than MUSA's 0.42% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
CCEL Cryo-Cell International, Inc. | 9.81% | 3.37% | 0.00% | 21.28% | 0.00% | 0.00% |
MUSA Murphy USA Inc. | 0.42% | 0.36% | 0.43% | 0.45% | 0.52% | 0.19% |
Drawdowns
CCEL vs. MUSA - Drawdown Comparison
The maximum CCEL drawdown since its inception was -96.67%, which is greater than MUSA's maximum drawdown of -33.72%. Use the drawdown chart below to compare losses from any high point for CCEL and MUSA. For additional features, visit the drawdowns tool.
Volatility
CCEL vs. MUSA - Volatility Comparison
Cryo-Cell International, Inc. (CCEL) and Murphy USA Inc. (MUSA) have volatilities of 16.66% and 16.04%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Financials
CCEL vs. MUSA - Financials Comparison
This section allows you to compare key financial metrics between Cryo-Cell International, Inc. and Murphy USA Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CCEL vs. MUSA - Profitability Comparison
CCEL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Cryo-Cell International, Inc. reported a gross profit of 5.98M and revenue of 7.97M. Therefore, the gross margin over that period was 75.1%.
MUSA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Murphy USA Inc. reported a gross profit of 599.00M and revenue of 4.71B. Therefore, the gross margin over that period was 12.7%.
CCEL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Cryo-Cell International, Inc. reported an operating income of 1.06M and revenue of 7.97M, resulting in an operating margin of 13.3%.
MUSA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Murphy USA Inc. reported an operating income of 199.00M and revenue of 4.71B, resulting in an operating margin of 4.2%.
CCEL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Cryo-Cell International, Inc. reported a net income of 282.86K and revenue of 7.97M, resulting in a net margin of 3.6%.
MUSA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Murphy USA Inc. reported a net income of 142.50M and revenue of 4.71B, resulting in a net margin of 3.0%.